Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Metavesco, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
0.03
0
0.08
0.13
Gross profit
0.03
0
Selling, general and administrative
0.21
0.27
0.1
0.07
0.06
0.07
0.16
0.31
Operating expenses
1.72
0.37
0.14
0.16
0.13
0.12
1.53
1.26
Operating income
-0.14
-0.16
-0.13
-0.12
Interest expense
0.04
0.09
0.07
0.05
0.01
0.1
Interest income
0
Other non-operating income
0.33
0.56
Net income
-1.68
-0.37
-0.14
10.4
-0.13
-0.12
-1.12
-0.57
EPS, basic
-0.88
-0.20
-0.07
5.44
-0.06
-0.02
-0.02
-0.01
EPS, diluted
-0.88
-0.20
-0.07
5.44
-0.06
-0.02
-0.02
-0.01
Shares, basic (weighted)
1.92
1.92
1.92
1.92
2.17
6.08
60.8
61.2
Shares, diluted (weighted)
1.92
1.92
1.92
1.92
2.17
6.08
60.8
61.2
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Cash and equivalents
0.46
0.02
0
0.01
0.01
0
0.04
0.02
Inventory
0.01
Other current assets
0.01
0.01
Total current assets
0.46
0
0.05
0.03
Property, plant and equipment
0
0.07
Goodwill
0
0
Intangible assets
0.43
0.04
Other non-current assets
0
Total assets
0.72
0
0
0.01
0.01
0
0.48
0.34
Accounts payable
0.01
0.01
0.01
0.02
0.03
0.06
Total current liabilities
10.9
10.6
10.7
0.19
0.13
0.21
0.13
0.22
Total liabilities
10.9
10.6
10.7
0.19
0.13
0.21
0.14
0.33
Total debt
0.1
Paid-in capital
15.5
15.5
15.5
15.6
11.6
17.7
19.4
19.6
Retained earnings
-28
-28
-28.1
-17.7
-17.8
-17.9
-19
-19.6
Shareholders' equity
-10.2
-10.6
-10.7
-0.18
-0.12
-0.21
0.34
0.01
Total equity
-10.2
-10.6
-10.7
-0.18
-0.12
-0.21
0.34
0.01
Total liabilities and equity
0.72
0
0
0.01
0.01
0
0.48
0.34
Shares outstanding
1.92
1.92
1.92
1.92
6.08
6.08
60.8
66.3
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Net income
-1.68
-0.37
-0.14
10.4
-0.13
-0.12
-1.12
-0.57
Depreciation and amortization
0
0
0.01
Change in inventory
-0
Change in payables
0.01
0
0
0.01
0
0.06
Cash from operations
-0.17
-0.27
-0.09
-0.07
-0.06
-0.06
-0.15
-0.2
Capital expenditures
-1.29
-0.06
Cash from investing
1.42
0.09
-1.29
0.16
Debt repaid
-1
-0.27
Cash from financing
-1
-0.27
0.1
0.07
0.06
0.05
1.48
0.02
Net change in cash
0.24
-0.46
0
0
0
-0.01
0.04
-0.02
Free cash flow
-1.44
-0.25
Interest paid
0.01
Key metrics
Worked out from the statements above. Latest values use fiscal 2023. Valuation uses the share price of $0.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Net margin
-450.8%
Net income / revenue.
FCF margin
-199.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-156.5%
Cash from operations / revenue.
Return on equity (ROE)
-326.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-139.7%
Net income / average total assets.
SG&A / revenue
246.7%
Selling, general and administrative expense / revenue.
Capex / revenue
43.3%
Capital expenditures / revenue.
D&A / revenue
8.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
53.8%
Revenue vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-98.1%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-30.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
198.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
135.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
204.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
99.9%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.15x
Current assets / current liabilities.
Quick ratio
0.08x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.08x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.01
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.00
Revenue / diluted weighted shares.
FCF per share
-$0.00
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.31x
Market cap / revenue.
P/B
6.22x
Market cap / shareholders' equity. Only when equity is positive.
EV/Sales
0.18x
Enterprise value / revenue.
FCF yield
-638.0%
Free cash flow / market cap.
Earnings yield
-1,440.0%
Net income / market cap (the inverse of P/E).
What was Metavesco, Inc.'s revenue in fiscal 2023?
Metavesco, Inc. reported revenue of $127.1K for fiscal 2023, 53.8% higher than the year before.
Was Metavesco, Inc. profitable in fiscal 2023?
No. It reported a net loss of $572.8K.
How much free cash flow did Metavesco, Inc. generate in fiscal 2023?
Cash from operations of $198.9K minus capital expenditures of $55.0K left free cash flow of -$253.9K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.